Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: Timing is everything

dc.contributor.authorConway, Jessica M.
dc.contributor.authorTuite, Ashleigh R.
dc.contributor.authorFisman, David N.
dc.contributor.authorHupert, Nathaniel
dc.contributor.authorMeza, Rafael
dc.contributor.authorDavoudi, Bahman
dc.contributor.authorEnglish, Krista
dc.contributor.authorVan den Driessche, Pauline
dc.contributor.authorMa, Junling
dc.date.accessioned2013-10-29T20:57:58Z
dc.date.available2013-10-29T20:57:58Z
dc.date.copyright2011en_US
dc.date.issued2011-12-14
dc.descriptionBioMed Centralen_US
dc.description.abstractBackground: Much remains unknown about the effect of timing and prioritization of vaccination against pandemic (pH1N1) 2009 virus on health outcomes. We adapted a city-level contact network model to study different campaigns on influenza morbidity and mortality. Methods: We modeled different distribution strategies initiated between July and November 2009 using a compartmental epidemic model that includes age structure and transmission network dynamics. The model represents the Greater Vancouver Regional District, a major North American city and surrounding suburbs with a population of 2 million, and is parameterized using data from the British Columbia Ministry of Health, published studies, and expert opinion. Outcomes are expressed as the number of infections and deaths averted due to vaccination. Results: The model output was consistent with provincial surveillance data. Assuming a basic reproduction number = 1.4, an 8-week vaccination campaign initiated 2 weeks before the epidemic onset reduced morbidity and mortality by 79-91% and 80-87%, respectively, compared to no vaccination. Prioritizing children and parents for vaccination may have reduced transmission compared to actual practice, but the mortality benefit of this strategy appears highly sensitive to campaign timing. Modeling the actual late October start date resulted in modest reductions in morbidity and mortality (13-25% and 16-20%, respectively) with little variation by prioritization scheme. Conclusion: Delays in vaccine production due to technological or logistical barriers may reduce potential benefits of vaccination for pandemic influenza, and these temporal effects can outweigh any additional theoretical benefits from population targeting. Careful modeling may provide decision makers with estimates of these effects before the epidemic peak to guide production goals and inform policy. Integration of real-time surveillance data with mathematical models holds the promise of enabling public health planners to optimize the community benefits from proposed interventions before the pandemic peak. en_US
dc.description.reviewstatusRevieweden_US
dc.description.scholarlevelFacultyen_US
dc.identifier.citationConway et al.: Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything. BMC Public Health 2011 11:932.en_US
dc.identifier.urihttp://www.biomedcentral.com/1471-2458/11/932
dc.identifier.urihttp://dx.doi.org/10.1186/1471-2458-11-932
dc.identifier.urihttp://hdl.handle.net/1828/5011
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.subject.departmentDepartment of Mathematics and Statistics
dc.titleVaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: Timing is everythingen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Conway_JessicaM_BMCPublicHealth_2011.pdf
Size:
320.44 KB
Format:
Adobe Portable Document Format
Description:
Conway_JessicaM_BMCPublicHealth_2011.pdf
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description: